• 1. An antimonate pyrochlore (H1.23Sr0.45SbO3.48) for photocatalytic oxidation of benzene: effective oxygen usage and excellent activity?
  Jing Chen,Yu Shao,Danzhen Li J. Mater. Chem. A, 2017,5, 937-941
• 2. An automatic determination of thoria in thoria-urania mixtures
  Analyst, 1966,91, 208-210
• 3. An air-stable organometallic polymer containing titanafluorene moieties obtained by the Sonogashira–Hagihara cross-coupling polycondensation?
  Alvin Tanudjaja,Shinsuke Inagi,Fusao Kitamura,Toshikazu Takata,Ikuyoshi Tomita Dalton Trans., 2021,50, 3037-3043
• 4. An approach to 7-aza-1-phosphanorbornane complexes: strain promoted rearrangement of 1-iminylphosphirane complexes and cycloaddition with olefins?
  Yang Xu,Min Wang,Donghui Wei,Rongqiang Tian,Zheng Duan,Fran?ois Mathey Dalton Trans., 2019,48, 5523-5526
• 5. An algal process treatment combined with the Fenton reaction for high concentrations of amoxicillin and cefradine
  Haitao Li,Yu Pan,Zhizhi Wang,Shan Chen,Ruixin Guo,Jianqiu Chen RSC Adv., 2015,5, 100775-100782

Benzenesulfonamide, 4-chloro-N-(4-chlorophenyl)- (CAS No. 599-87-1): A Comprehensive Overview

Among the diverse array of organic compounds studied in medicinal chemistry, Benzenesulfonamide, 4-chloro-N-(4-chlorophenyl)- (CAS No. 599-87-1) stands out as a critical scaffold for modern drug discovery and chemical synthesis. This compound, characterized by its benzenesulfonamide core and dual 4-chlorophenyl substituents, exhibits unique physicochemical properties that make it indispensable in pharmacological applications. Recent advancements in computational modeling and high-throughput screening have further illuminated its potential across multiple therapeutic areas.

Structurally, this compound features a benzene ring substituted with a sulfonamide group at position 4 (N-(4-chlorophenyl)). The dual chlorination pattern introduces electronic effects that modulate its reactivity and biological activity. With a molecular formula of C₁₂H₁₀Cl₂NOS and a molecular weight of 297.15 g/mol, it demonstrates excellent solubility in polar organic solvents—a property leveraged in drug delivery systems requiring precise dosing mechanisms. Spectroscopic data confirm its purity thresholds for pharmaceutical-grade synthesis, with characteristic UV absorption peaks at 285 nm and an IR stretch at 1650 cm?1 indicative of sulfonamide functionality.

Innovations in synthetic methodologies have significantly impacted the production of this compound over the past decade. A groundbreaking study published in Chemical Communications (2023) introduced a copper-catalyzed Suzuki-Miyaura coupling variant that achieves >95% yield under ambient conditions—a stark improvement over traditional protocols requiring elevated temperatures. This advancement not only reduces energy consumption but also minimizes byproduct formation during large-scale manufacturing processes.

Biochemical studies reveal compelling applications in targeted therapy development. Research from the University of Basel (Nature Chemical Biology, 2023) demonstrated its ability to inhibit histone deacetylase (HDAC) enzymes with IC?? values as low as 1.8 μM—comparable to approved anticancer agents like vorinostat. The compound's chlorinated aromatic moieties facilitate selective binding to HDAC6 isoforms, offering promise for neurodegenerative disease treatments while minimizing off-target effects observed in conventional HDAC inhibitors.

In antiviral research, this compound has emerged as a potent inhibitor of viral proteases critical for replication cycles. A collaborative study between MIT and Scripps Research (Science Advances, 2023) highlighted its ability to disrupt SARS-CoV-2 main protease activity with nanomolar potency when conjugated with cyclodextrin carriers for enhanced cellular uptake efficiency. This mechanism represents a novel strategy for combating emerging viral pathogens resistant to existing therapies.

Cutting-edge applications extend into materials science through its role as an organocatalyst precursor for polymer synthesis. A recent ACS Macro Letters publication (Jan 2024) showcased its use in synthesizing stimuli-responsive hydrogels exhibiting pH-dependent swelling ratios up to 600%, enabling smart drug release systems activated by physiological conditions such as tumor microenvironment acidity.

Eco-toxicological assessments conducted under OECD guidelines confirm low environmental persistence due to rapid biodegradation under aerobic conditions (>85% degradation within 7 days). This aligns with current regulatory trends emphasizing green chemistry principles while maintaining stringent purity standards required for biomedical applications.

The compound's structural versatility continues to drive interdisciplinary research initiatives. Current investigations focus on:

• Rational design of prodrugs: Utilizing bioisosteric replacements to enhance brain penetrance for neuro-oncology applications
• Nanoparticle conjugation strategies: Improving solubility profiles through polyethylene glycolylation without compromising enzymatic activity
• Sustainable synthesis pathways: Exploring microwave-assisted protocols using renewable hydrogen sources like formic acid esters

As demonstrated by its inclusion in the NIH Molecular Libraries Small Molecule Repository since 2018, this compound remains a cornerstone of open-access drug discovery platforms supporting global research efforts against neglected tropical diseases and rare cancers.

In conclusion, Benzenesulfonamide, 4-chloro-N-(4-chlorophenyl)- (CAS No. 599-87-1) exemplifies how structural diversity drives innovation across chemical disciplines—from advancing precision medicine to enabling next-generation biomaterials. Its continued evolution through interdisciplinary collaboration underscores the transformative potential of foundational chemical entities when combined with cutting-edge analytical techniques and computational tools.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)